SciSight Ecosystem
WoS SCIE Q4Scopus Q3SCImago #16,289CAS 4区Hybrid

ASSAY and Drug Development Technologies

Abbreviation (ISO):ASSAY DRUG DEV. TECHNOL
Country: United States•WoS SCIE Quartile: Q4•Scopus SJR: 0.327•SCImago Rank: #16,289•Identifier (ISSN):1540-658X(Print)/1557-8127(Online)•Articles / Year: 39•Estimated Publication Fee (APC): $2,730 USD
Clarivate IF (2026)Q4
1.8
↑ +0.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
52

52 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate6.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
39articles/year
2% Gold OA•88.89% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 1.8)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 1.8)
🔵 Computed
20251.50đ
WoS Q3(IF: 1.7)
🔵 Computed
20241.50đ
WoS Q3(IF: 1.6)
🔵 Computed
20231.50đ
WoS Q3(IF: 1.8)
🔵 Computed
20221.50đ
WoS Q3(IF: 2.471)
🔵 Computed
20211.50đ
WoS Q3(IF: 1.738)
🔵 Computed
20201.50đ
WoS Q3(IF: 1.187)
🔵 Computed
20191.50đ
WoS Q3(IF: 1.42)
🔵 Computed
20181.50đ
WoS Q3(IF: 1.593)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application. ASSAY and Drug Development Technologies coverage includes: -Assay design, target development, and high-throughput technologies- Hit to Lead optimization and medicinal chemistry through preclinical candidate selection- Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis- Approaches to assays configured for gene families, inherited, and infectious diseases- Assays and strategies for adapting model organisms to drug discovery- The use of stem cells as models of disease- Translation of phenotypic outputs to target identification- Exploration and mechanistic studies of the technical basis for assay and screening artifacts

Topics Covered (Recognized by AI)
Biology83.4%Chemistry75.5%Biochemistry66.3%Medicine61.8%Genetics61.7%Internal medicine42.2%Physics33.2%Computational biology32.8%Gene30.9%Organic chemistry30.9%Computer science29.9%Bioinformatics28.1%Psychology27.6%Cell biology26.7%Pharmacology26%Receptor23%

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #16,289Scopus Q3SCImago Profile
Scopus Coverage:2002-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.327

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q3
Scopus H-Index (2025)
68

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.30

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,730 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations202
3-Year Documents98
Citable Documents90

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate38.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ3
Molecular MedicineQ4

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区BIOCHEMICAL RESEARCH METHODS
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Mary Ann Liebert Inc.
Publication Language
English
Frequency
Bimonthly
Founding Year
2002
Editorial Address
MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
BIOCHEMICAL RESEARCH METHODS
JCRSCIE
67/85Q4
PHARMACOLOGY & PHARMACY
JCRSCIE
258/356Q3
BIOCHEMICAL RESEARCH METHODS
JCISCIE
70/85Q4
PHARMACOLOGY & PHARMACY
JCISCIE
259/356Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—267
20251.740101
20241.633144
20231.841212
20222.47138283
20211.73855335
20201.18750564
20191.4247694
20181.59349448
2017—46480
2016—64858
2015—841,551
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for ASSAY and Drug Development Technologies

WoS Q4
0123201820192020202120222023202420251.70
Annual Impact Factor Metric
2025:1.7

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: fcae374d-3f58-44f8-92ff-b563b4bdc5af
Database Updated: 2026-09-28